Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis
Article in Translational Psychiatry (July 2023)
The most recent citing publications are shown below. View all 32 publications that cite this research output on Dimensions.
Rivastigmine for Cognitive Impairment in Multiple Sclerosis: A Prospective Randomized Open Label study with Blinded End-Point Assessment.
Article in Neurology India (January 2023)
The SAGE Handbook of Clinical Neuropsychology
Book (January 2023)